AHMEADBAD: Zydus Cadila has filed another IND (Investigational New Drug) application for the New Molecular Entity (NME), ZYO1, a novel drug candidate for treating obesity and related disorders with the Drug Controller General of India (DCGI). ZYO1, according to the company, is a novel experimental drug working through CB-1 mechanism, which will help obese patients lose weight, and also help in controlling blood sugar levels in type-2 diabetes.